UBS Group AG - UNIVERSE PHARMACEUTICALS INC ownership

UNIVERSE PHARMACEUTICALS INC's ticker is UPC and the CUSIP is G9442G104. A total of 5 filers reported holding UNIVERSE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of UNIVERSE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$6,670
+33.4%
4,600
-49.0%
0.00%
Q3 2022$5,000
+400.0%
9,014
+1958.0%
0.00%
Q1 2022$1,000
-90.9%
438
-93.6%
0.00%
Q4 2021$11,000
+266.7%
6,860
+501.2%
0.00%
Q3 2021$3,0000.0%1,141
+24.2%
0.00%
Q2 2021$3,000
-97.9%
919
-97.4%
0.00%
Q1 2021$140,00035,0000.00%
Other shareholders
UNIVERSE PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 239,482$150,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
ACADIAN ASSET MANAGEMENT LLC 13,299$8,0000.00%
TWO SIGMA SECURITIES, LLC 16,349$10,0000.00%
Renaissance Technologies 20,520$13,0000.00%
View complete list of UNIVERSE PHARMACEUTICALS INC shareholders